1
|
Desgrouas C, Thalheim T, Cerino M, Badens C, Bonello-Palot N. Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans. Cardiovasc Res 2024; 120:237-248. [PMID: 38214891 DOI: 10.1093/cvr/cvae005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 10/12/2023] [Accepted: 10/27/2023] [Indexed: 01/13/2024] Open
Abstract
The function of perilipin 1 in human metabolism was recently highlighted by the description of PLIN1 variants associated with various pathologies. These include severe familial partial lipodystrophy and early onset acute coronary syndrome. Additionally, certain variants have been reported to have a protective effect on cardiovascular diseases. The role of this protein remains controversial in mice and variant interpretation in humans is still conflicting. This literature review has two primary objectives (i) to clarify the function of the PLIN1 gene in lipid metabolism and atherosclerosis by examining functional studies performed in cells (adipocytes) and mice and (ii) to understand the impact of PLIN1 variants identified in humans based on the variant's location within the protein and the type of variant (missense or frameshift). To achieve these objectives, we conducted an extensive analysis of the relevant literature on perilipin 1, its function in cellular models and mice, and the consequences of its mutations in humans. We also utilized bioinformatics tools and consulted the Human Genetics Cardiovascular Disease Knowledge Portal to enhance the pathogenicity assessment of PLIN1 missense variants.
Collapse
Affiliation(s)
- Camille Desgrouas
- Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France
| | - Tabea Thalheim
- Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France
| | - Mathieu Cerino
- Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France
- AP-HM, Service de Biochimie, Hôpital de la Timone 264 rue Saint Pierre 13005 Marseille, France
| | - Catherine Badens
- Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France
- AP-HM, Service de Biochimie, Hôpital de la Timone 264 rue Saint Pierre 13005 Marseille, France
- Département de Génétique Médicale, APHM, Hôpital Timone Enfants, Hôpital de la Timone 264 rue Saint Pierre 13005 Marseille, France
| | - Nathalie Bonello-Palot
- Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France
- Département de Génétique Médicale, APHM, Hôpital Timone Enfants, Hôpital de la Timone 264 rue Saint Pierre 13005 Marseille, France
| |
Collapse
|
2
|
Varlet AA, Desgrouas C, Jebane C, Bonello-Palot N, Bourgeois P, Levy N, Helfer E, Dubois N, Valero R, Badens C, Beliard S. A Rare Mutation in LMNB2 Associated with Lipodystrophy Drives Premature Cell Senescence. Cells 2021; 11:50. [PMID: 35011612 PMCID: PMC8750194 DOI: 10.3390/cells11010050] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Revised: 12/16/2021] [Accepted: 12/22/2021] [Indexed: 11/16/2022] Open
Abstract
Many proteins are causative for inherited partial lipodystrophies, including lamins, the essential constituents of the nuclear envelope scaffold called the lamina. By performing high throughput sequencing on a panel of genes involved in lipodystrophies, we identified a heterozygous mutation in LMNB2 gene (c.700C > T p.(Arg234Trp)) in a female patient presenting early onset type II diabetes, hypertriglyceridemia, and android fat distribution. This mutation is rare in the general population (frequency 0.013% in GnomAD) and was predicted pathogenic by a set of pathogenicity prediction software. Patient-derived fibroblasts showed nuclear shape abnormalities and premature senescence features, which are two typical cellular phenotypes associated with laminopathies. Moreover, we observed an atypical aggregation of lamin B2 in nucleoplasm, which co-distributes with emerin and lamin A/C, along with an abnormal distribution of lamin A/C at the nuclear envelope. Finally, reducing lamin B2 expression level by siRNA targeted toward LMNB2 transcripts resulted in decreased nuclear anomalies and senescence-associated beta-galactosidase, suggesting a role of the mutated protein in the occurrence of the observed cellular phenotype. Altogether, these results suggest that mutations in lamin B2 could produce premature senescence and partial lipodystrophy features as observed with certain mutants of lamin A/C.
Collapse
Affiliation(s)
- Alice-Anaïs Varlet
- Aix Marseille Univ, INSERM, MMG, 13385 Marseille, France; (A.-A.V.); (C.D.); (N.B.-P.); (P.B.); (N.L.)
| | - Camille Desgrouas
- Aix Marseille Univ, INSERM, MMG, 13385 Marseille, France; (A.-A.V.); (C.D.); (N.B.-P.); (P.B.); (N.L.)
- Aix Marseille Univ, Laboratoire de Chimie Analytique, Faculté de Pharmacie, 13005 Marseille, France
| | - Cécile Jebane
- Aix Marseille Univ, CNRS, CINAM, Turing Centre for Living Systems, 13288 Marseille, France; (C.J.); (E.H.)
| | - Nathalie Bonello-Palot
- Aix Marseille Univ, INSERM, MMG, 13385 Marseille, France; (A.-A.V.); (C.D.); (N.B.-P.); (P.B.); (N.L.)
- APHM, Department of Genetics, 13385 Marseille, France
| | - Patrice Bourgeois
- Aix Marseille Univ, INSERM, MMG, 13385 Marseille, France; (A.-A.V.); (C.D.); (N.B.-P.); (P.B.); (N.L.)
- APHM, Department of Genetics, 13385 Marseille, France
| | - Nicolas Levy
- Aix Marseille Univ, INSERM, MMG, 13385 Marseille, France; (A.-A.V.); (C.D.); (N.B.-P.); (P.B.); (N.L.)
- APHM, Department of Genetics, 13385 Marseille, France
| | - Emmanuèle Helfer
- Aix Marseille Univ, CNRS, CINAM, Turing Centre for Living Systems, 13288 Marseille, France; (C.J.); (E.H.)
| | - Noémie Dubois
- APHM, Metabolic Diseases, Endocrinology, Department of Nutrition, 13385 Marseille, France; (N.D.); (R.V.); (S.B.)
| | - René Valero
- APHM, Metabolic Diseases, Endocrinology, Department of Nutrition, 13385 Marseille, France; (N.D.); (R.V.); (S.B.)
- Aix Marseille Univ, INSERM, INRAE, C2VN, 13385 Marseille, France
| | - Catherine Badens
- Aix Marseille Univ, INSERM, MMG, 13385 Marseille, France; (A.-A.V.); (C.D.); (N.B.-P.); (P.B.); (N.L.)
- APHM, Department of Genetics, 13385 Marseille, France
| | - Sophie Beliard
- APHM, Metabolic Diseases, Endocrinology, Department of Nutrition, 13385 Marseille, France; (N.D.); (R.V.); (S.B.)
- Aix Marseille Univ, INSERM, INRAE, C2VN, 13385 Marseille, France
| |
Collapse
|